Loading...
Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
BACKGROUND: Lutetium 177 ((177)Lu) - DOTATATE is a form of peptide receptor radionuclide therapy (PRRT) utilized in the treatment of neuroendocrine tumors. Data on (177)Lu-DOTATATE-induced thyroid dysfunction is limited. CASE DESCRIPTION: A 29-year-old male with SDHB positive metastatic paragangliom...
Na minha lista:
| Udgivet i: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859638/ https://ncbi.nlm.nih.gov/pubmed/33551992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.587065 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|